Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

University of Toronto

$105,490.00

Tissue engineered retina

EF 2009-10

Résumé
Regenerative Medicine holds tremendous promise for overcoming diseases and disorders that the body cannot heal on its own. By combining tissue engineering with stem cell biology strategies, we propose to create an artificial retina that will be available for transplantation to restore vision when it is lost due to disease or degeneration. This proposal advances exciting research at the interface of engineering and medicine. We will build on our fundamental invention that combines advanced laser technology with photochemically activated hydrogels to create 3-dimensional, chemically patterned hydrogel scaffolds. These hydrogels will mimic the laminar structure present in the retina and have specific factors immobilized in defined volumes that will preferentially guide and differentiate retinal stem cells to the four main cell types of the retina that are required to process and produce signals. By incorporating endothelial precursor cells into the scaffold design, we will achieve a vascularized retina tissue analog where the nascent blood vessels will ensure cell and tissue survival. We will test the tissue engineered retina for function in vitro and for biocompatibility and cell survival in vivo. Our multidisciplinary team is poised for success in this challenging project that combines engineering, photochemistry, stem cell biology, electrophysiology and animal studies. Each team member brings the complementary expertise that is required to achieve the proposed goals. The HQP trained in this project will benefit from the diverse expertise and the consequent breadth of training received. With a view toward translation, the team is supported by an industrial partner who will work with us to patent and commercialize inventions derived herein. Together we aim to advance the underlying science required in tissue engineering to restore vision.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
338535-2007
Name nom
Shoichet, Molly
Department département
Chemical Engineering and Applied Chemistry
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2007
Award amount
105490
Program id
CHRPJ
Program nane en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
3
Nb partie
3
Application title
Tissue engineered retina
Keyword
NA
Application summary
Regenerative Medicine holds tremendous promise for overcoming diseases and disorders that the body cannot heal on its own. By combining tissue engineering with stem cell biology strategies, we propose to create an artificial retina that will be available for transplantation to restore vision when it is lost due to disease or degeneration. This proposal advances exciting research at the interface of engineering and medicine. We will build on our fundamental invention that combines advanced laser technology with photochemically activated hydrogels to create 3-dimensional, chemically patterned hydrogel scaffolds. These hydrogels will mimic the laminar structure present in the retina and have specific factors immobilized in defined volumes that will preferentially guide and differentiate retinal stem cells to the four main cell types of the retina that are required to process and produce signals. By incorporating endothelial precursor cells into the scaffold design, we will achieve a vascularized retina tissue analog where the nascent blood vessels will ensure cell and tissue survival. We will test the tissue engineered retina for function in vitro and for biocompatibility and cell survival in vivo. Our multidisciplinary team is poised for success in this challenging project that combines engineering, photochemistry, stem cell biology, electrophysiology and animal studies. Each team member brings the complementary expertise that is required to achieve the proposed goals. The HQP trained in this project will benefit from the diverse expertise and the consequent breadth of training received. With a view toward translation, the team is supported by an industrial partner who will work with us to patent and commercialize inventions derived herein. Together we aim to advance the underlying science required in tissue engineering to restore vision.